Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243958 | SCV000309521 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000833946 | SCV000975714 | likely benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Clinical Genomics, |
RCV004021010 | SCV005016439 | likely benign | Diabetic retinopathy | criteria provided, single submitter | research | Potent mutations in TGFBR2 gene encodes the transforming growth factor that have been associated with angiogenesis and diabetic retinopathy. More clinical studies are needed for stronger association. However, more evidence is required to confer the association of this particular variant rs11466495 with diabetic retinopathy. | |
Breakthrough Genomics, |
RCV000833946 | SCV005258383 | likely benign | not provided | criteria provided, single submitter | not provided |